Fatty liver disease (FLD) is a common and reversible (treatable) condition in which fat cells build up in the liver.The disease is divided into two main types: alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). The nonalcoholic type is often associated with obesity, type 2 diabetes, insulin resistance, and metabolic syndrome. The disease is initially asymptomatic, but over time it can lead to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even liver cancer (hepatocellular carcinoma). Diagnosis is usually made using imaging techniques such as ultrasound, CT (computed tomography), MRI (magnetic resonance imaging), liver function tests, and in some cases, a biopsy. Current treatments focus primarily on lifestyle changes—weight loss, dietary changes, increased physical activity, and control of metabolic disorders. Drug research is ongoing, but there is no universally approved specific treatment.Early detection and treatment are essential to prevent disease progression and improve patient quality of life and outcomes.[1]